Get started
Author

Т. В. Поварова

Observed names: T. Povarova, T. V. Povarova, Tatyana Povarova, Поварова Т. В., Поварова Т.В.
Institution: Russian Railways
Observed institution: Russian Railways
ORCID: 0000-0002-7304-6769
Observed ORCID: 0000-0002-7304-6769
OpenAlex ID: A5012081749
Efficacy and safety of netakimab, anti-IL-17A monoclonal antibody, in patients with ankylosing spondylitis. Results of phase III international, multicenter, randomized double-blind clinical trial BCD-085-5/ASTERA
2020 · V. I. Mazurov, I. Z. Gaydukova, et al. · Rheumatology Science and Practice · 19
PDF
Effectiveness and safety of BCD180, anti-TRBV9+ T-lymphocytes monoclonal antibody in patients with active radiographic axial spondyloarthritis: 36-week results of double-blind randomized placebo-controlled phase II clinical study ELEFTA
2024 · E. L. Nasonov, V. I. Mazurov, et al. · Rheumatology Science and Practice · 18
PDF
Long-term efficacy and safety of netakimab in the treatment of ankylosing spondylitis: results of Phase III international, multicenter, randomized double-blind clinical trial BCD-085-5/ASTERA
2020 · V. I. Mazurov, Sh. F. Erdes, et al. · Modern Rheumatology Journal · 17
PDF
The Efficacy and Safety of BCD-180, an Anti-TRBV9+ T cell Monoclonal Antibody, in Patients with Active Radiographic Axial Spondyloarthritis: 36-week Results from the Randomized, Double-Blind, Placebo-Controlled Phase 2 Clinical Study ELEFTA
2025 · E. L. Nasonov, V. I. Mazurov, et al. · Doklady Biochemistry and Biophysics · 14
Effectiveness and safety of levilimab in combination with methotrexate in treatment of patients with active rheumatoid arthritis resistant to methotrexate monotherapy (double-blinded randomized placebo controlled phase III clinical study SOLAR)
2021 · V. I. Mazurov, M. A. Korolev, et al. · Modern Rheumatology Journal · 14
PDF
Long-term efficacy and safety of netakimab in patients with active ankylosing spondylitis: results of three years of use in the international multicentre, randomized, double-blind, phase III clinical trial BCD-085-5/ASTERA
2024 · V. I. Mazurov, Sh. F. Erdes, et al. · Modern Rheumatology Journal · 9
PDF
Comparative efficacy and safety of infliximab biosimilar (BCD-055) and innovator infliximab in patients with ankylosing spondylitis (results of international, multiple-center, double-blind phase I and phase III clinical studies)
2017 · D. E. Karateev, V. I. Mazurov, et al. · Modern Rheumatology Journal · 6
PDF
Efficacy and Safety of Levilimab in Combination with Methotrexate in Patients with Active Rheumatoid Arthritis: 56-Week Results of Phase III Randomized Double-Blind Placebo-Controlled Trial SOLAR
2024 · V. I. Mazurov, E. L. Nasonov, et al. · Doklady Biochemistry and Biophysics · 5
Efficacy and safety of levilimab in combination with methotrexate in patients with active rheumatoid arthritis: 56-week results of phase III randomized double-blind placebo-controlled trial SOLAR
2023 · V. I. Mazurov, A. M. Lila, et al. · Rheumatology Science and Practice · 5
PDF
Real-world retention rate, effectiveness, and safety of netakimab in the treatment of patients with ankylosing spondylitis: First year results of the LIBRA post-registration safety study
2023 · Sh. Erdes, V. I. Mazurov, et al. · Rheumatology Science and Practice · 4
PDF
Efficacy and safety of a new original interleukin 17A inhibitor in the treatment of patients with active ankylosing spondylitis: results of a basic (BCD-085-3/AILAS) and extended (BCD-085-3ext/AILAS-II) phase II clinical trial
2019 · Sh. Erdes, V. I. Mazurov, et al. · Rheumatology Science and Practice · 4
PDF
Op0232 Netakimab Reduces the Disease Activity of Radiographic Axial Spondyloarthritis. Results of Astera Study
2019 · Inna Gaydukova, V Mazurov, et al. · Annals of the Rheumatic Diseases · 4
PDF
The Efficacy and Safety of Divozilimab in Patient with Systemic Sclerosis: 48-Week Results of the Randomized Double-Blind Placebo-Controlled Phase III Clinical Study LIBERIUS
2025 · L. P. Ananyeva, M. N. Starovoytova, et al. · Doklady Biochemistry and Biophysics · 3
PDF
Pos0624 Efficacy and Safety of Levilimab in Combination With Methotrexate in Subjects With Active Rheumatoid Arthritis: Phase Iii, Double-blind, Placebo-controlled, Randomized Trial
2021 · V. Mazurov, M. Korolev, et al. · Annals of the Rheumatic Diseases · 3
PDF
Comparative Evaluation of the Long-term Efficacy and Safety of the Infliximab Biosimilar Bcd-055 and Reference Infliximab in Patients With Ankylosing Spondylitis: Results of the International Multicenter Randomized Double-blind Phase Iii Clinical Study Asart-2
2018 · A. M. Lila, V. I. Mazurov, et al. · Rheumatology Science and Practice · 3
Long-term effects of netakimab on health-related quality of life, back pain and work productivity in patients with ankylosing spondylitis: results of the international, multicentre, randomized double-blind phase III clinical trial BCD-085-5/ASTERA
2023 · T. V. Dubinina, A. B. Demina, et al. · Modern Rheumatology Journal · 2
PDF
Real-world retention rate, effectiveness, and safety of netakimab in the treatment of patients with ankylosing spondylitis: Two-year results of the real word evidence LIBRA study
2025 · Sh. F. Erdes, V. I. Mazurov, et al. · Rheumatology Science and Practice · 1
PDF
Натрийуретические пептиды и галектин-3 у пациентов старческого возраста с хронической сердечной недостаточностью с сохраненной фракцией выброса
2015 · Lidia I. Malinova, Р. А. Подболотов, et al. · DOAJ (DOAJ: Directory of Open Access Journals) · 1
Real-World Retention Rate, Effectiveness, and Safety of Netakimab in the Treatment of Patients with Ankylosing Spondylitis: Two-Year Results of the Real Word Evidence LIBRA Study
2026 · Sh. F. Erdes, V. I. Mazurov, et al. · Doklady Biochemistry and Biophysics
Extract of oak bark as a selective natural reagent for the spectrophotometric determination of iron (II) in pharmaceutical preparations and blood serum
2025 · V. I. Mazurov, A. M. Lila, et al. · Rheumatology Science and Practice
Slowing the progression of ankylosing spondylitis during long-term therapy with netakimab: results of the international multicenter randomized double-blind phase III clinical trial BCD-085-5/ASTERA
2025 · V. I. Mazurov, A. M. Lila, et al. · Modern Rheumatology Journal
PDF
Efficacy of divozilimab in the treatment of systemic sclerosis: results of the randomized phase III clinical trial BCD-132-5/LIBERIUS
2025 · L. P. Ananyeva, M. N. Starovoytova, et al. · Modern Rheumatology Journal
PDF
Real-World Retention Rate, Effectiveness, and Safety of Netakimab in the Treatment of Patients with Ankylosing Spondylitis: First Year Results of the LIBRA Post-Registration Safety Study
2024 · Sh. Erdes, V. I. Mazurov, et al. · Doklady Biochemistry and Biophysics
Pos0649 Efficacy and Safety of Levilimab in Combination With Methotrexate in Patients With Active Rheumatoid Arthritis: 1-year Results of Phase Iii, Double-blind, Placebo-controlled, Randomized Trial
2022 · V. Mazurov, M. Korolev, et al. · Annals of the Rheumatic Diseases
PDF
Попибиомаркерный подход к оценке миокарди-альной дисфункции у пациентов старческого возраста
2015 · Lidia I. Malinova, Р. А. Подболотов, et al. · DOAJ (DOAJ: Directory of Open Access Journals)
Works count: 30
Citation count: 132
H-index: 6
I10-index: 5
Year
Topic
Type